COMMUNIQUÉS West-GlobeNewswire

MDxHealth (R) : MDxHealth Notice of Interim Results 2018
10/08/2018
NEWS RELEASE REGULATED INFORMATION Conference call for analysts and investors to be held on 30 August 2018 at 15:00 CEST IRVINE, CA, and HERSTAL, BELGIUM - 08.00 CEST, 10 August 2018 - MDxHealth SA (Euronext: MDXH.BR) [...]
MDxHealth (R) : Avis de publication des résultats semestriels 2018
10/08/2018
C ommuniqué de presse Information réglementée Une conférence téléphonique pour les analystes et les investisseurs est prévue le 30 août 2018 à 15:00 CET IRVINE, CA, et HERSTAL (BELGIQUE) - 08.00 CET, le 10 août 2018 - [...]
Shire plc : Rule 2.9 Announcement
10/08/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 10 August 2018 [...]
Interim report for the first half of 2018
10/08/2018
Satisfactory first half with 4% organic sales growth Organic sales growth of +4% in the first half (Q2: +5%): Household Care -1%, Food & Beverages +4%, Bioenergy +14%, Agriculture & Feed +3%, Technical & [...]
ObsEva SA to Participate in Wedbush PacGrow Healthcare Conference August 14-15, 2018
10/08/2018
Geneva, Switzerland and Boston, MA - August 10, 2018 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a Swiss clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for [...]
MDxHealth (R): MDxHealth Shareholder Transparency Declaration
10/08/2018
Press release Regulated information 7 August 2018, 7.00 p.m. CET HERSTAL, BELGIUM and IRVINE, CA - August 7, 2018 - MDxHealth SA (Euronext Brussels: MDXH) ("MDxHealth" or the "Company"), announced that it received on [...]
MDxHealth (R) : MDxHealth: Déclaration de Transparence d'un Actionnaire
10/08/2018
C ommuniqué de presse Information réglementée 7 août 2018, 07h00 HEC IRVINE, CA, et HERSTAL (BELGIQUE) - le 7 août 2018 - MDxHealth SA (Euronext Brussels: MDXH) ("MDxHealth" ou la "Société"), a annoncé avoir reçu le 3 [...]
NeoGenomics Announces Pricing on Public Offering of Common Stock
10/08/2018
FT. MYERS, Fla., Aug. 09, 2018 (GLOBE NEWSWIRE) -- NeoGenomics, Inc. (NASDAQ: NEO) , a leading provider of cancer-focused genetic testing services, today announced the pricing of its underwritten public offering of 9, [...]
MacroGenics to Present at Wedbush PacGrow Healthcare Conference
10/08/2018
ROCKVILLE, MD, Aug. 09, 2018 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for [...]
Kane Biotech Retains Strategic Expert in Securing Non-Dilutive Funding Opportunities in the United States
09/08/2018
WINNIPEG, Manitoba, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE, OTCQB:KNBIF), (the “Corporation” or “Kane Biotech”) today announced the engagement of Dave D. Hood, President and Chief Executive [...]
Extendicare Announces 2018 Second Quarter Results
09/08/2018
MARKHAM, Ontario, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today reported results for the three and six months ended June 30, 2018. Results are presented in Canadian [...]
Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2019 Ended June 30, 2018 and Provides Conference Call Information
09/08/2018
Conference Call Scheduled for Friday, August 10th at 11:00 AM EDT NORTHVALE, N.J., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP), a specialty pharmaceutical [...]
MediPharm Labs Continues to Strengthen Leadership Team for Growth
09/08/2018
Not for distribution to United States newswire services or for release publication, distribution or dissemination directly, or indirectly, in whole or in part, in or into the United States. TORONTO, Aug. 09, 2018 (GLOBE [...]
Molecular Templates, Inc. Reports Second Quarter 2018 Financial Results
09/08/2018
AUSTIN, Texas, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq:MTEM, “Molecular” or “Molecular Templates”), a clinical-stage oncology company focused on the discovery and development of the company’s [...]
Denali Therapeutics Reports Second Quarter 2018 Financial Results
09/08/2018
SOUTH SAN FRANCISCO, Calif., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ:DNLI), a biopharmaceutical company developing a broad portfolio of product candidates for neurodegenerative diseases, today [...]
Terra Tech Corp Reports Financial Results for the Second Quarter of 2018
09/08/2018
IRVINE, Calif., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Terra Tech Corp. (OTCQX: TRTC) (“Terra Tech” or the “Company”), a vertically integrated cannabis-focused agriculture company, today announced its second quarter [...]
Abeona Therapeutics Reports Second Quarter 2018 Financial Results and Business Highlights
09/08/2018
Investor Conference Call on Friday, August 10th at 10:00 am ET NEW YORK and CLEVELAND, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq:ABEO), a leading clinical-stage biopharmaceutical company focused [...]
Aeterna Zentaris Reports Second Quarter 2018 Financial and Operating Results
09/08/2018
Macrilen™ (macimorelin) Successfully Launched in the U.S. in July CHARLESTON, S.C., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS), a biopharmaceutical company engaged in developing [...]
Translate Bio Announces Second Quarter 2018 Financial Results and Highlights Recent Development and Corporate Achievements
09/08/2018
-- Initiated Phase 1/2 clinical trial of MRT5005 in patients with cystic fibrosis -- -- Established strategic mRNA vaccines partnership with Sanofi Pasteur -- -- Completed initial public offering raising approximately $ [...]

Pages